PPT-Gynecologic problems in Brest cancer

1 drug 2hot flash 3sexual dysfunction Tamoxifen tamoxifen CLINICAL PRESENTATION AND EVALUATION . Magee-. Womens. Hospital of UPMC. Clinical and Research Updates in Gynecologic Oncology. Gynecologic Cancer in the United States. American Cancer Society, 2017. New Cases. Cancer Deaths. Ovary. 22,440. A Centers for Disease Control and Prevention Campaign. What We Will Discuss. Part I. What You Need to Know About Gynecologic Cancers. Part II: Recognizing the Warning Signs. Part III: Prevention, Screening, and Treatment. Protocol GOG-0258. Louise E. Francis, B.S., CMD. Gynecologic Oncology Group. . (GOG). The only National Cancer Institute funded cooperative group. . in the US currently conducting trials 0n gynecologic cancers. Nelson Teng, M.D., Ph.D.. Director, Gynecologic Oncology. Stanford University School of Medicine. Disclosures. I do not have any conflict of interest to report. Acknowledgement. Dr. . Jakob. . Dupont. The George W. Morley Professor University of Michigan What is gynecologic cancer? begin in the female reproductive organs. The most common gynecologic cancers are endometrial cancer, ovarian cancer an organs: cervical, ovarian, uterine, vaginal, and vulvar. As a group, they are referred to as gynecologic (GY-neh-kuh-LAH-jik) cancer. (A sixth type of gynecologic cancer is the very rare fallopian tub reproductive organs: cervical, ovarian, uterine, vaginal, and vulvar. As a group, they are referred to as gynecologic (GY-neh-kuh-LAH-jik) cancer. (A sixth type of gynecologic cancer is the very rare reproductive organs: cervical, ovarian, uterine, vaginal, and vulvar. As a group, they are referred to as gynecologic (GY-neh-kuh-LAH-jik) cancer. (A sixth type of gynecologic cancer is the very rare — What you should know…. General 1. Do not leave the hospital w/o asking your resident if they need any further help. 2. No one leaves clinic until every pt has been seen. 3. Don’t forget to go the development research projects and educational the past at an the management malignant neoplasm requires a multi- disciplinary approach, which includes Gynecologic Oncology years. During subspecial Department of Obstetrics and Gynecology ________________________________________________________________________________________________________Division of Gynecologic OncologyEducationProgram for Fel N=5. Mean=8.6 . SD=19.5. N=53. Mean=15.6 . SD=19.6. N=52. Mean=26.8 . SD=47.3. N=288. Mean=21.1 . SD=28.1. N=283. Mean=12.2 . SD=14.5. N=293. N=292, Mean=33.9, SD=50.34. N=275, Mean=31.7, SD=26.3. N=245. 2,3. Emily V. Dressler, PhD. 4. ; David I. Shalowitz, MD, MSHP. 1,2.  . 1 . Section on Gynecologic Oncology, Department of Obstetrics and . Gynecology, . 2 . Department of Implementation . Science, . Amy Klapheke, MPH, PhD. Public Health Institute, Cancer Registry of Greater California. NAACCR/IACR Combined Annual Conference. June 11, 2019. Outline. Background. Methods. Results. Discussion. Background.